COVID-19 流行病对泰国住院结核病患者死亡率的影响,以及医院病例和严重程度的调解作用
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。虽然COVID-19大流行导致结核病病例数量减少,但结核病病例死亡率增加. 这种结核病死亡人数的增加与入院的严重病例有关,而不是医院的质量下降.
科学领域
- 公共卫生
- 传染性疾病
- 流行病学
背景情况
- 医院病例数量,特别是在COVID-19大流行期间,反映了医疗保健系统的压力和资源分配.
- 了解COVID-19对结核病 (TB) 等其他疾病的影响对于公共健康至关重要.
- 该研究调查了COVID-19医院负担如何影响结核病患者的结果.
研究的目的
- 评估COVID-19医院病例对结核病死亡率的影响.
- 确定这种影响是否由结核病例或患者严重程度的变化造成.
- 在疫情期间评估结核病患者的医院护理质量.
主要方法
- 泰国结核病患者住院数据的回顾性分析 (2017-2022年).
- 使用查尔森并发症指数 (CCI) 来量化患者的严重程度.
- 使用中断时间序列,延迟时间和串行调解分析.
主要成果
- 在COVID-19期间,每月结核病患者数量减少12.9%,每月结核病患者数量增加14.1%.
- COVID-19病例与结核病例负相关 (r=-0.60) 和结核病CFR正相关 (r=0.74).
- 在对结核病例数和患者严重程度 (CCI) 进行调整后,发现COVID-19病例数和结核病医院CFR之间没有直接联系.
结论
- 在COVID-19大流行期间观察到的结核病医院CFR的增加主要归因于入院的严重结核病例比例较高.
- 这表明结核病患者的医院护理质量并不一定下降.
- 这些发现突显了流行病与现有疾病管理之间的复杂相互作用.
相关概念视频
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
• Class zero: The individual has no known TB exposure and has a negative tuberculin skin test.
• Class one: The individual has been exposed to...
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
• For...